Narula Neerja, Yamamura Deborah L R, Marshall John K
Department of Medicine (Division of Gastroenterology) and Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada.
Can J Gastroenterol. 2010 Feb;24(2):121-5. doi: 10.1155/2010/375878.
Crohn's disease and ulcerative colitis are variants of inflammatory bowel disease (IBD) for which immunosuppressive therapy is often required. Immunosuppressed patients are at increased risk for infections, including vaccine-preventable diseases such as influenza. Although several guidelines recommend routine influenza immunization for such patients, recent literature suggests that this patient population may be inadequately immunized. Current research suggests that inactivated influenza vaccines are effective, well tolerated and can be administered safely in most IBD patients. Studies in other immunosuppressed populations have also demonstrated the safety of inactivated vaccines. The present article reviews the literature regarding the safety and efficacy of influenza vaccination in IBD patients receiving immunosuppressive therapy.
克罗恩病和溃疡性结肠炎是炎症性肠病(IBD)的变体,通常需要进行免疫抑制治疗。免疫抑制患者发生感染的风险增加,包括流感等可通过接种疫苗预防的疾病。尽管多项指南建议对此类患者进行常规流感疫苗接种,但最近的文献表明,这一患者群体的疫苗接种可能不足。目前的研究表明,灭活流感疫苗是有效的,耐受性良好,并且在大多数IBD患者中可以安全接种。在其他免疫抑制人群中进行的研究也证明了灭活疫苗的安全性。本文综述了关于接受免疫抑制治疗的IBD患者接种流感疫苗安全性和有效性的文献。